search
Back to results

Improving Care for Patients With High Blood Pressure

Primary Purpose

Hypertension, Cardiovascular Disease Risk

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Complex quality improvement intervention
Sponsored by
University of North Carolina, Chapel Hill
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension focused on measuring hypertension, genomics

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Men and women who meet the following inclusion criteria will be eligible for study participation:
  • 18 years or older,
  • Able and willing to give informed consent,
  • A current patient of 1 of the 5 participating practices,
  • Have a current diagnosis of hypertension by their primary care physician or have 3 documented blood pressures above 150/90,
  • Their most recent systolic blood pressure was greater than or equal to 150 at their most recent clinic visit,
  • Receive physician approval to participate in the study.
  • Anyone enrolled in the High Blood Pressure study is eligible to participate in the genomics component of the project.

Exclusion Criteria:

  • non-English speaking,
  • current treatment of psychosis,
  • diagnosed with advanced dementia as determined by the clinician,
  • current substance abuse,
  • lack of phone access,
  • history of malignancy, other than non-melanoma skin cancer, that has not been in remission or cured surgically for > 5 years,
  • estimated creatinine clearance less than 30 ml/min (because hypertension management becomes more complicated at this point),
  • are pregnant.

Sites / Locations

  • Kinston Enterprise Center - Study Office

Outcomes

Primary Outcome Measures

systolic blood pressure
We will measures blood pressure at enrollment and then every 6 months for 24 months.

Secondary Outcome Measures

Blood lipids
We will measure blood lipids including total cholesterol and HDL over the course of the study to calculate overall cardiovascular risk.
General Cardiovascular Disease Risk
We will measure variables (blood pressure, cholesterol, aspirin use, smoking status, and diabetes status) to calculate general cardiovascular disease risk which includes (coronary death, myocardial infarction, coronary insufficiency, angina, ischemic stroke, hemorrhagic stroke, transient ischemic attack, peripheral artery disease, heart failure). (D'Agostino, 2008)
Genomic predictors of blood pressure change
A systems approach to developing genomic models integrating clinical and genomic data.

Full Information

First Posted
August 26, 2011
Last Updated
November 17, 2014
Sponsor
University of North Carolina, Chapel Hill
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
search

1. Study Identification

Unique Protocol Identification Number
NCT01425515
Brief Title
Improving Care for Patients With High Blood Pressure
Official Title
Heart Healthy Lenoir: Improving Care for Patients With High Blood Pressure
Study Type
Interventional

2. Study Status

Record Verification Date
November 2014
Overall Recruitment Status
Completed
Study Start Date
September 2011 (undefined)
Primary Completion Date
October 2014 (Actual)
Study Completion Date
October 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of North Carolina, Chapel Hill
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators are conducting a single group intervention study to improve blood pressure control and reduce racial and literacy related disparities among people with hypertension. The intervention includes providing patients with home blood pressure monitors, administering phone-coaching to participants, and improving hypertension care at the participating practices from which patients are enrolled. The investigators will follow the patients for 2 years to determine if blood pressure control improves. In addition, the project will explore genetic factors associated with cardiovascular disease risk and treatment success.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension, Cardiovascular Disease Risk
Keywords
hypertension, genomics

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
535 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Complex quality improvement intervention
Intervention Description
We are implementing a complex quality improvement intervention that includes changes in practice processes to enhance hypertension care, provision of home blood pressure monitors to patients, and telephone coaching around hypertension self-management.
Primary Outcome Measure Information:
Title
systolic blood pressure
Description
We will measures blood pressure at enrollment and then every 6 months for 24 months.
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Blood lipids
Description
We will measure blood lipids including total cholesterol and HDL over the course of the study to calculate overall cardiovascular risk.
Time Frame
2 years
Title
General Cardiovascular Disease Risk
Description
We will measure variables (blood pressure, cholesterol, aspirin use, smoking status, and diabetes status) to calculate general cardiovascular disease risk which includes (coronary death, myocardial infarction, coronary insufficiency, angina, ischemic stroke, hemorrhagic stroke, transient ischemic attack, peripheral artery disease, heart failure). (D'Agostino, 2008)
Time Frame
2 years
Title
Genomic predictors of blood pressure change
Description
A systems approach to developing genomic models integrating clinical and genomic data.
Time Frame
6-, 12-, 18, and 24-month follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men and women who meet the following inclusion criteria will be eligible for study participation: 18 years or older, Able and willing to give informed consent, A current patient of 1 of the 5 participating practices, Have a current diagnosis of hypertension by their primary care physician or have 3 documented blood pressures above 150/90, Their most recent systolic blood pressure was greater than or equal to 150 at their most recent clinic visit, Receive physician approval to participate in the study. Anyone enrolled in the High Blood Pressure study is eligible to participate in the genomics component of the project. Exclusion Criteria: non-English speaking, current treatment of psychosis, diagnosed with advanced dementia as determined by the clinician, current substance abuse, lack of phone access, history of malignancy, other than non-melanoma skin cancer, that has not been in remission or cured surgically for > 5 years, estimated creatinine clearance less than 30 ml/min (because hypertension management becomes more complicated at this point), are pregnant.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jacqueline Halladay, MD
Organizational Affiliation
University of North Carolina, Chapel Hill
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kinston Enterprise Center - Study Office
City
Kinston
State/Province
North Carolina
ZIP/Postal Code
28501
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
18212285
Citation
D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.
Results Reference
background
PubMed Identifier
30282468
Citation
Cummings DM, Adams A, Halladay J, Hinderliter A, Donahue KE, Cene CW, Li Q, Miller C, Garcia B, Tillman J, Little E, DeWalt D. Race-Specific Patterns of Treatment Intensification Among Hypertensive Patients Using Home Blood Pressure Monitoring: Analysis Using Defined Daily Doses in the Heart Healthy Lenoir Study. Ann Pharmacother. 2019 Apr;53(4):333-340. doi: 10.1177/1060028018806001. Epub 2018 Oct 3.
Results Reference
derived
PubMed Identifier
28569683
Citation
Chatterjee A, Daftary G, Gatison L, Gillman MW. Lessons Learned From a Partnership to Evaluate a School Food Program. Prog Community Health Partnersh. 2016;10(4):577-584. doi: 10.1353/cpr.2016.0066.
Results Reference
derived
PubMed Identifier
26334761
Citation
Cummings DM, Wu JR, Cene C, Halladay J, Donahue KE, Hinderliter A, Miller C, Garcia B, Penn D, Tillman J, DeWalt D. Perceived Social Standing, Medication Nonadherence, and Systolic Blood Pressure in the Rural South. J Rural Health. 2016 Spring;32(2):156-63. doi: 10.1111/jrh.12138. Epub 2015 Sep 3.
Results Reference
derived
PubMed Identifier
24156629
Citation
Halladay JR, Donahue KE, Hinderliter AL, Cummings DM, Cene CW, Miller CL, Garcia BA, Tillman J, DeWalt D; Heart Healthy Lenoir Research Team. The Heart Healthy Lenoir project--an intervention to reduce disparities in hypertension control: study protocol. BMC Health Serv Res. 2013 Oct 25;13:441. doi: 10.1186/1472-6963-13-441.
Results Reference
derived
Links:
URL
http://hpdp.unc.edu/research/projects/heart-healthy-lenoir/
Description
Summary information about the Heart Healthy Lenoir Project

Learn more about this trial

Improving Care for Patients With High Blood Pressure

We'll reach out to this number within 24 hrs